Related Experiment Video
Updated: Apr 9, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
miR-21 Modulates the Immunoregulatory Function of Bone Marrow Mesenchymal Stem Cells Through the PTEN/Akt/TGF-β1
Tingting Wu1, Yi Liu2, Zhipeng Fan3
1Molecular Laboratory for Gene Therapy and Tooth Regeneration.
Abstract:
microRNAs (miRNAs) act as regulatory signals for maintaining stemness, self-renewal, and differentiation of mesenchymal stem cells (MSCs), but whether miRNAs modulate the immunoregulatory function of MSCs remains largely unknown. Here, we show that miR-21 negatively regulates the activity of immunoregulatory cytokine transforming growth factor-β1 (TGF-β1) in MSCs. Consistently, bone marrow MSCs (BMMSCs) from miR-21(-/-) mice show enhanced immunosuppressive function by more TGF-β1 secretion and induce more CD4(+) Foxp3(+) regulatory T cells compared with wild-type BMMSCs in vitro, which anti-TGF-β1 antibody abrogates. Mechanistically, miR-21 inhibits TGF-β1 expression by targeting phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in BMMSCs. Downstream of PTEN, miR-21 promotes activation of Akt, and consequently increases activation of NF-κB pathway. Importantly, adoptive transfer of miR-21(-/-) BMMSCs into mice with experimental colitis more effectively ameliorates colonic inflammation in a TGF-β1-dependent manner. Thus, these findings indicate a previously uncovered mechanism of miR-21 control immunoregulatory function of BMMSCs through TGF-β1 inhibition.
Insights
MicroRNA-21 (miR-21) suppresses the immune function of mesenchymal stem cells (MSCs) by inhibiting transforming growth factor-β1 (TGF-β1). Deleting miR-21 enhances MSCs
Area of Science:
- Immunology
- Stem Cell Biology
- Molecular Biology
Background:
- Mesenchymal stem cells (MSCs) possess immunomodulatory properties.
- The role of microRNAs (miRNAs) in regulating MSC immunomodulation is not fully understood.
- MicroRNA-21 (miR-21) is implicated in stem cell functions but its effect on MSC immunomodulation is unclear.
Purpose of the Study:
- To investigate the role of miR-21 in modulating the immunoregulatory function of MSCs.
- To elucidate the molecular mechanism by which miR-21 affects MSC immunomodulation.
- To assess the therapeutic potential of miR-21-deficient MSCs in an inflammatory disease model.
Main Methods:
- Utilized miR-21 knockout (miR-21(-/-)) and wild-type (WT) bone marrow MSCs (BMMSCs).
- Assessed TGF-β1 secretion, regulatory T cell induction, and downstream signaling pathways (PTEN, Akt, NF-κB).
- Evaluated the efficacy of miR-21(-/-) BMMSCs in a mouse model of experimental colitis.
Main Results:
- miR-21(-/-) BMMSCs exhibited enhanced immunosuppressive function compared to WT BMMSCs.
- miR-21(-/-) BMMSCs secreted more TGF-β1, leading to increased CD4(+) Foxp3(+) regulatory T cell induction.
- miR-21 targets PTEN, inhibiting the TGF-β1 pathway and consequently suppressing Akt and NF-κB activation.
- Adoptive transfer of miR-21(-/-) BMMSCs ameliorated experimental colitis in a TGF-β1-dependent manner.
Conclusions:
- miR-21 negatively regulates the immunoregulatory function of MSCs by inhibiting TGF-β1.
- The miR-21/PTEN/TGF-β1 axis is a key mechanism controlling MSC immunomodulation.
- miR-21-deficient MSCs represent a potential cell-based therapy for inflammatory diseases.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
MicroRNAs
MicroRNAs
TGF - β Signaling Pathway

